The FDA requested Fresenius Medical Care to issue a Naturalyte Liquid Acid Concentrate recall and a Naturalyte GranuFlo recall after receiving a complaint about alkali dosing errors. Fresenius Medical Care is being investigated by the FDA for failure to timely inform the public of serious risks surrounding use of these kidney dialysis products. Granuflo dosing errors may lead to dialysis heart attack, stroke, or even death. A Naturalyte Liquid Acid Concentrate recall and Naturalyte GranuFlo recall was initiated in June 2012, and lawyers are investigating possible GranuFlo lawsuits. If these dialysis products harmed you or a loved one, you should speak with an attorney to protect your rights.